Beth Hecht's Net Worth

$4.07 Million

Estimate Recalculated Jul 2, 2024 04:36PM EST

Who is Beth Hecht?

Beth Hecht has an estimated net worth of $4.07 Million. This is based on reported shares across multiple companies, which include Xeris Biopharma Holdings, Inc., XERIS PHARMACEUTICALS INC, Neos Therapeutics, Inc., AYTU BIOPHARMA, INC, and Iterum Therapeutics plc.

SEC CIK

Beth Hecht's CIK is 0001652410

Past Insider Trading and Trends

2021 was Beth Hecht's most active year for acquiring shares with 11 total transactions. Beth Hecht's most active month to acquire stocks was the month of September. 2021 was Beth Hecht's most active year for disposing of shares, totalling 13 transactions. Beth Hecht's most active month to dispose stocks was the month of February. 2019 saw Beth Hecht paying a total of $38,674.69 for 83,490 shares, this is the most they've acquired in one year. In 2021 Beth Hecht cashed out on 627,581 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Xeris Biopharma Holdings, Inc. (XERS) Snapshot price: $2.63

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+93.17%
750K
—
—
1.55M
Jan 31
Form 4
+78.17%
350K
—
—
797.76K
Jan 31
Form 4
+106.22%
225K
—
—
436.82K
Jan 3
Form 4
∞
206.37K
—
—
206.37K
Oct 5
Form 3
—
0
—
—
0
No matching records found

XERIS PHARMACEUTICALS INC No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-206.37K
—
—
0
Oct 5
Form 4
+246.65%
150K
—
—
210.81K
Jan 29
Form 4
—
0
—
—
0
Aug 14
Form 4
+6.54%
3.73K
$2.26
$8,432.06
60.81K
Jun 30
Form 4
+7.54%
4K
$1.97
$7,880.00
57.08K
Mar 13
Form 4
+556.72%
45K
—
—
53.08K
Jan 31
Form 4
+97.97%
4K
$4.15
$16,600.00
8.08K
Feb 14
Form 4
+12.67%
459
$5.99
$2,749.41
4.08K
Dec 31
Form 4/A
—
0
—
—
0
Form 4
+40.09%
1.12K
$9.72
$10,925.28
3.93K
Jul 1
Form 4
∞
2.5K
$10.00
$25,000.00
2.5K
Feb 19
Form 4
—
0
—
—
0
Jan 31
Form 3
—
0
—
—
0
No matching records found

Neos Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-23.45K
—
—
0
Mar 19
Form 4
∞
23.45K
—
—
23.45K
Jun 10
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jul 3
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+254.70%
6.5K
—
—
9.05K
Apr 8
Form 3
—
0
—
—
0
No matching records found

Iterum Therapeutics plc (ITRM) Snapshot price: $1.7299

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+530.91%
15.85K
—
—
18.84K
Jun 15
Form 4
+459.57%
36.8K
—
—
44.8K
Jun 23
Form 4
—
0
—
—
0
Jun 15
Form 4
+2,093.70%
7.64K
—
—
8.01K
Mar 18
Form 4
—
0
—
—
0
Jun 23
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Mar 18
No matching records found